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Abstract
Remote ischemic postconditioning (RIPostC) is a promising therapeutic intervention whereby brief episodes of ischemia/
reperfusion of one organ (limb) mitigate damage in another organ (brain) that has experienced severe hypoxia-ischemia.
Our aim was to assess whether RIPostC is protective following cerebral hypoxia-ischemia in a piglet model of neonatal
encephalopathy (NE) using magnetic resonance spectroscopy (MRS) biomarkers and immunohistochemistry. After
hypoxia-ischemia (HI), 16 Large White female newborn piglets were randomized to: (i) no intervention (n¼ 8); (ii)
RIPostC – with four, 10-min cycles of bilateral lower limb ischemia/reperfusion immediately after HI (n¼ 8). RIPostC
reduced the hypoxic-ischemic-induced increase in white matter proton MRS lactate/N acetyl aspartate (p¼ 0.005) and
increased whole brain phosphorus-31 MRS ATP (p¼ 0.039) over the 48 h after HI. Cell death was reduced with RIPostC
in the periventricular white matter (p¼ 0.03), internal capsule (p¼ 0.002) and corpus callosum (p¼ 0.021); there was
reduced microglial activation in corpus callosum (p¼ 0.001) and more surviving oligodendrocytes in corpus callosum
(p¼ 0.029) and periventricular white matter (p¼ 0.001). Changes in gene expression were detected in the white matter
at 48 h, including KATP channel and endothelin A receptor. Immediate RIPostC is a potentially safe and promising brain
protective therapy for babies with NE with protection in white but not grey matter.
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Introduction
Intrapartum-related hypoxic ischemic events are a sig-
niﬁcant global burden with 1.15 million babies each
year developing neonatal encephalopathy (NE).1 The
majority (96%) of NE occurs in low and middle-
income settings, where mortality and neuroimpairment
rates are high.1 In high-income settings where neonatal
intensive care of a high quality is routinely available,
therapeutic hypothermia is a safe and standard practice
for term infants diagnosed with NE.2 There is clear
evidence that therapeutic hypothermia in this setting
reduces adverse outcome at 18 months of age (typical
RR 0.75, conﬁdence interval: 0.68–0.83)2; this improve-
ment persists into childhood resulting in widespread
beneﬁt to society, individuals and the economy.3
However, therapeutic hypothermia is only partially
eﬀective as a neuroprotective therapy for NE as over
45% of infants have adverse neurodevelopmental out-
comes despite treatment. Moreover, eﬀective cooling
treatment requires a high level of neonatal intensive
care support, which is not available in many lower-
resource settings. There is an urgent need to develop
additional simple, safe and eﬀective neuroprotective
treatment strategies that can be used alone or with
hypothermia.
Organisms have evolved mechanisms to protect
against tissue damage and to compensate and regener-
ate after injury. There is a growing interest in harness-
ing endogenous protective strategies to protect the
brain from reperfusion injury.4 Ischemic precondition-
ing is a powerful innate protective mechanism against
ischemia-reperfusion injury that has evolved in mam-
malian species. Ischemic preconditioning describes brief
non-cell-lethal episodes of ischemia which confer pro-
tection against a subsequent sustained period of severe
ischemia in the same organ and was ﬁrst described in
the myocardium in 1986.5 Ischemic postconditioning
(IPostC) evolved from this concept6 and is deﬁned as
intermittent interruptions in blood ﬂow at the time of
reperfusion after the severe ischemia in the same
organ.7 IPostC has an obvious therapeutic timing
advantage over preconditioning and the beneﬁts of
IPostC appear to be mediated by similar molecular
pathways.8 In adult rodent models of stroke, IPostC
reduced cerebral infarct size in focal7 and global ische-
mia9 and was eﬀective if performed on a non-vital
organ, such as the limb, remote to the aﬀected organ
– remote IPostC (RIPostC).10 RIPostC can be imme-
diate (applied within a few minutes of reperfusion) or
delayed (applied hours to weeks after reperfusion). Ren
and colleagues have shown that both immediate and
delayed RIPostC provide protection in adult rats and
improve neurologic function two months after the
ischemic insult.10 In neonatal rodent stroke models,
reduced infarct volumes and improved neurological
outcomes were observed with four 10-min cycles of
ischemia and reperfusion of both hindlimbs started
immediately after HI.11 Even with a 24-h delay after
HI in the start of RIPostC, there were improved sen-
sory motor outcomes ﬁve weeks after the ischemic
insult, although the infarct size was not reduced.12
The objective of this study was to assess whether
immediate RIPostC is protective following a global
cerebral hypoxic ischemic insult in a piglet model of
perinatal asphyxia. This model has strong similarities
to newborn infants with NE in terms of the timing of
the evolution of injury after hypoxia-ischemia (HI),13,14
the pattern of injury, neuropathology and cerebral
magnetic resonance spectroscopy (MRS).15 In addition,
meticulous intensive care monitoring and support of
the piglet maintain physiological and metabolic stabil-
ity. RIPostC treatment eﬃcacy was explored using clin-
ically relevant biomarkers of in vivo proton (1H) MRS
for lactate, N-acetyl aspartate (Naa), creatine16 and
phosphorus-31 (31P) MRS for inorganic phosphate,
phosphocreatine and NTP.13 At 48 h after HI, histo-
logical assessment of cell death was performed using
TUNEL, cell-speciﬁc labeling to measure glial number
(S100B and Oligo2), microglial activation (Iba1), and
activation of endothelial cells (eNOS). Underlying
putative neuroprotective mechanisms were investigated
with exploratory genome microarray and qualitative
reverse transcription polymerase reaction (qRT-PCR).
Materials and methods
Sample size calculation
Our primary outcomes were cerebral lactate/Naa and
NTP/exchangeable phosphate pool (epp). Previous
work with our model suggested that the change in lac-
tate/Naa during 48 h varied between normo- and hypo-
thermic groups by 1.0U, with a standard deviation of
0.75U (both log scale). Assuming similar magnitude of
additional eﬀect for RIPostC following HI versus HI
alone and with 5% signiﬁcance and 80% power, eight
subjects were required in each group.
Animal experiments and surgical preparation
All animal experiments were approved by the Ethics
Committee of University College London and per-
formed according to the UK Home Oﬃce Guidelines
[Animals (Scientiﬁc procedures) Act, 1986]. The study
complies with the ARRIVE guidelines. Sixteen female
piglets, aged less than 30 h, with a weight range of 1.6–
2.1 kg were anesthetized and surgically prepared as
described previously.14 The study time-line is shown
in Figure 1(a). Studies were started around 9 am and
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Figure 1. (a). Study time-line. Following baseline data acquisition, piglets underwent cerebral hypoxia-ischemia. At the end of
hypoxia-ischemia (time 0), piglets were randomized to (i) HI or (ii) HIþRIPostC. RIPostC was started immediately at Time 0. Piglets
(Continued)
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all studies were performed in the same laboratory.
Following initial assessment for any signs of obvious
infection including diarrhea and conjunctivitis, an
intramuscular dose of 0.2mg/kg of midazolam was
administered for sedation. Anesthesia was induced by
4% v/v isoﬂurane through a facemask for around 5min
to facilitate tracheostomy and intubation. Throughout
the surgery, isoﬂurane was maintained at 2.8–3%
guided by peripheral oxygen saturation monitoring
(Nonin Medical, Plymouth, MN, USA) and the ani-
mal’s response to stimulation. Following tracheostomy,
a suitable size of endotracheal tube (Smiths Medical,
Ashford, Kent, UK) was ﬁxed and the piglet was mech-
anically ventilated (SLE 2000 infant ventilator, Surrey,
UK). Ventilator settings were adjusted to maintain par-
tial pressure of oxygen (PaO2) at 8–13 kPa and carbon
dioxide (PaCO2) at 4.5–6.5 kPa, allowing for tempera-
ture and fraction of inspired oxygen (FiO2) correction
of the arterial blood sample.
After the airway was secured, both common carotid
arteries were surgically isolated at the level of the
fourth cervical vertebra and a vascular occluder
(OC2A, In Vivo Metric, Healdsburg, CA, USA) was
placed on each side. After completion of surgery, the
inspired isoﬂurane concentration was maintained at
2% v/v.
An umbilical venous catheter was inserted for infu-
sion of maintenance ﬂuids (10% dextrose, 60ml/kg/day
before the insult and 40ml/kg/day after resuscitation),
fentanyl (5 mg/kg/h), and antibiotics (benzyl penicillin
50mg/kg, every 12 h and gentamicin 4mg/kg, once a
day). An umbilical arterial catheter was inserted for
invasive physiologic monitoring (SA instruments) for
heart rate and arterial blood pressure, and blood sam-
pling for arterial gases and electrolytes (Abbot
Laboratories, UK). Hepsal (0.5 IU/ml of heparin in
0.9% saline solution) was infused at rate of 0.3ml/h
to prevent umbilical arterial catheter blockage.
After surgery, and before securing piglets in the
custom-built holder, the postconditioning device was
placed over both inguinal canals and strapped diag-
onally across the inguinal region overlying an inﬂatable
bladder. To assess limb perfusion during and after
RIPostC, a separate pulse oximeter was attached to
right hind limb, while laser Doppler assessed perfusion
on the left side. An additional pulse oximeter was
attached to right forelimb to monitor the systemic
oxygen saturation.
Piglets were cared for under intensive care condi-
tions throughout the experiment. To maintain the
MABP above 40mmHg, bolus infusions of 0.9%
saline (Baxter; 10ml/kg), dopamine (5–20 mg/kg/min),
dobutamine (5–20mg/kg/min) and adrenaline (0.1–
1.5 mg/kg/min) were used as required by a NICU
trained clinician. High serum lactate was treated by
optimizing oxygenation and administering 0.45%
saline bolus infusions. Hyperkalemia (K> 7.0mmol/l)
was treated with 4mcg/kg salbutamol (10mcg/ml)
through the umbilical venous catheter over 10min.
Calcium gluconate (0.5ml/kg of 10% solution) was
administered slowly to stablize the myocardium when
ECG changes or hypocalcemia (ionized calcium
<1mmol/l) occurred. In the presence of metabolic acid-
osis, a half correction of sodium bicarbonate was given
after ensuring adequate ventilation.
MR methods
The head was immobilized in a stereotactic frame for
MRS acquisition. Piglets were positioned within the
bore of 9.4 Tesla Agilent MR scanner. 1H and 31P
MRS spectra were acquired at baseline and at 24 and
48 h after cerebral HI, described below.
31P MRS. A 7 cm 5 cm elliptical transmit-receive MRS
surface coil tuned to the 31P resonant frequency (51.6
MHz) was positioned on top of the head. 31P MRS was
acquired with 1-min resolution using a non-localized
single-pulse surface-coil acquisition (repetition time
10 s, six summed acquisitions per spectrum). MRS
data were analyzed using AMARES17 as implemented
in the jMRUI software. Prior knowledge of NTP multi-
plet structure was used (ﬁtting doublets to a- and g-
NTP and a triplet to b-NTP), but no assumption was
Figure 1. Continue.
were maintained under meticulous intensive care for 48 h at which point (*) they were euthanized. MRS was acquired at baseline,
during HI, for the first 60 min after HI, and at 24 and 48 h. NIRS was acquired at baseline, during HI and throughout the four RIPostC
cycles. EEG was acquired at baseline and in between the MRS acquisitions. (b) Side view of the RIPostC device remotely controlled in
the bore of the 9.4 Tesla MR system. The top panel shows the device during the reperfusion period with the occluder in its resting
position. The lower panel shows the inflated air bladder pushing the occluder forward to compress the femoral artery lying below. (c)
The occluders are shown here with occlusion of both femoral arteries inducing lower limb ischemia. The lower limbs are clearly
cyanosed. Limb ischemia was further confirmed by loss of the signal from the pulse oximeter and laser doppler in both limbs. (d)
Diagram showing the complete RIPostC system used to remotely occlude both femoral arteries in the magnet. The closed system was
connected to a nitrogen gas cylinder; pressure sensors allowed the gas pressure to be measured. The device was controlled by the
inflation buttons, which allowed gas to enter the system, inflate the bladders, and occlude the femoral arteries.
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made as to multiplet relative sizes. NTP is predomin-
ately ATP and the latter contributes approximately
70% of the NTP signal.18 Thus, NTP changes during
this experiment predominately reﬂected ATP changes.
Pi was ﬁtted using four separate components and PCr
with a single component. The following peak-area
ratios were calculated: Pi/epp, PCr/epp, and NTP/epp
where epp¼ exchangeable phosphate pool¼Piþ
PCrþ 2g-NTPþ b-NTP.
1H MRS. 1H MRS data were collected from voxels
located in the dorsal right subcortical white matter at
the centrum semiovale level (white matter voxel,
8 8 15mm) and in the deep grey matter centered
on both lateral thalami (deep grey matter voxel,
15 15 10mm) using a combination of a
65 55mm elliptical receive surface coil, a 150mm
transmit volume coil and a LASER acquisition
(TR¼ 5000ms, TE¼ 288ms, 128 averages). Spectra
were analyzed using AMARES as implemented in the
jMRUI software and the lactate/Naa peak ratio was
calculated.
Statistics. Analyses were carried out using Stata 13.
MRS data were analyzed by ﬁtting a mixed eﬀects
linear regression model with a random subject eﬀect
included in the model for each metabolite ratio. The
variance–covariance structure of these models allows
for the fact that two observations from an individual
subject are more likely to be similar than are observa-
tions from two diﬀerent subjects. Measurement time
points are referred to as baseline, 24 h post HI and
48 h post HI. Fitting an interaction term between the
time and the treatment group allowed diﬀerent regres-
sion slopes for each time and group combination to be
estimated.
Cerebral hypoxia–ischemia (HI)
NIRS and 31P MRS were acquired continuously for
10min at baseline, during HI, and for 1 h after cessa-
tion of HI. HI was induced inside the MR scanner by
remotely inﬂating the vascular occluders around both
common-carotid arteries, and simultaneously reducing
FiO2 to 6% (vol/vol). During HI, the b-NTP peak
height was continuously monitored using in-house
Matlab (Mathworks) software. At the point at which
b-NTP had fallen to 50% of its baseline value, FiO2
was increased to 9%. When b-NTP fell to 40% baseline
height, the inspired oxygen fraction was titrated to keep
the b-NTP peak height between 30% and 40% of its
original height for a period of 12.5min. At the end of
HI, the carotid arteries were de-occluded and the FiO2
returned to 21%. Insult severity was estimated by cal-
culating the time integral of the change in NTP/epp
during HI and the ﬁrst 60 minutes of resuscitation, as
described previously.19
Remote ischemic postconditioning method/device
We designed a purpose built RIPostC device, suited to
piglet anatomy. Computer-aided design software was
used (Autodesk Inventor Professional 2013) to 3D
print the device (Selective Laser Sintering) in nylon.
The V-shaped device was secured by Velcro straps dir-
ectly over the inguinal creases and femoral arteries.
Occlusion of the femoral arteries leading to bilateral
limb ischemia was induced by inﬂation of the air blad-
der within the device; this pushed the occluder down-
wards out of the device to compress the femoral artery
lying below (Figure 1b and c). Reperfusion was induced
by deﬂation of the air bladder within the device; this
allowed the occluder to return back into the device.
This was performed remotely by a controller (Figure
1d), which consisted of two solenoid valves (2 port
VDW10 series, SMC Pneumatics LTD, Crownhill,
UK), one to gate the inﬂow of high-pressure nitrogen
for inﬂation, and the second as an exhaust to control
deﬂation. The pressure in the air bladder was measured
using an electronic sensor (MPX5050, Freescale
Semiconductor, Arizona, USA) and monitored con-
tinuously using a microcontroller (Arduino Uno).
During each 10-min inﬂation, the bladders were main-
tained at a pressure of at least 40 kPa. A LCD display
was used to provide visual feedback of the bladder pres-
sure, and display the elapsed time since the last inﬂa-
tion/deﬂation. An analogue voltage display
proportional to the pressure within the PC device,
and a digital gating signal (high when inﬂated) were
shown on the front panel for monitoring and recording.
Experimental groups
Following resuscitation, while in the bore of the MR
system, piglets were randomized (computer generated
randomization revealed after HI to minimize bias) into
two groups – HI or HI with remote ischemic postcon-
ditioning (HIþRIPostC) (Figure 1a). There were eight
animals in each group. In the HI group, the postcondi-
tioning device was ﬁtted but not inﬂated. In the
HIþRIPostC group, immediately after resuscitation,
piglets underwent four cycles of 10-min ischemia fol-
lowed by 10-min reperfusion in both hindlimbs using
the RIPostC device. Limb ischemia was conﬁrmed by
laser Doppler velocimetry in the left hindlimb and pulse
oximetry of the right hindlimb. Both groups were cared
for over 48 h after HI and maintained normothermic
(38–38.5C). Physiological parameters were compared
between groups with Mann–Whitney at each time
point.
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Electroencephalography and amplitude-integrated
electroencephalography
A six lead EEG was acquired between MRI studies.
aEEG background voltage activity was classiﬁed
according to al Naqueeb et al.20 Grade 3 was assigned
to normal voltage (upper margin> 10 mV, lower
margin> 5 mV); Grade 2 to moderately abnormal volt-
age (upper margin> 10 mV, lower margin 5 mV) and
Grade 1 assigned to severely abnormal aEEG (upper
margin< 10mV, lower margin< 5 mV). aEEG grading
was performed at baseline (before insult), 3, 6, 12, 24,
36 and 48 hours post insult. An ordered logistic regres-
sion model was ﬁtted to the data, allowing for repeated
measurements over time in each pig to estimate the
odds ratio (OR) of change in aEEG with RIPostC.
Brain histology
Piglets were euthanized by pentobarbital injected at
48 h after the HI insult and the brain ﬁxed via cardiac
perfusion with cold PBS, followed by 4% paraformal-
dehyde in PBS. After nine days post-ﬁxation in 2%
paraformaldehyde, 5mm thick coronal slices of the
right hemisphere from the optic chiasma were pro-
cessed to paraﬃn wax, sectioned (8 mm) and stained
with hematoxylin and eosin to validate the bregma
for analysis. For each animal, two sections (bregma
00 and 2.0) were stained (described below) and 12
diﬀerent regions in the brain were examined.
TUNEL staining for DNA fragmentation and
immunohistochemistry (IHC) were performed as pre-
viously described.21 In brief, TUNEL sections were
pre-treated in 3% hydrogen peroxide, subjected to a
protease K pre-digestion (Promega, Southampton,
UK) and incubated with TUNEL solution (Roche,
Burgess Hill, UK). TUNEL was visualized using
avidin-biotinylated horseradish complex (ABC, Vector
Laboratories, Peterborough, UK) and diaminobenzi-
dine/H2O2 (DAB, Sigma, Poole, UK) enhanced with
CoSO4 and NiCl2. For IHC, sections were rehydrated,
heat treatment used for antigen retrieval and following
blocking with appropriate serum together with 0.1
Triton in PBS, sections were incubated with primary
antibody overnight at 4 C: Iba1 (1:1000; Wako,
Osaka, Japan); S100 (1:800, Abcam, Cambridge,
UK); Olig2 (1:400, Millipore, Nottingham, UK);
eNOS (1:1000, BD Biosciences, Oxford, UK).
Sections were incubated with a biotinylated secondary
antibody (1:250) and staining was visualized using ABC
(both Vector Laboratories) and DAB (Sigma). TUNEL
and IHC sections were dehydrated and cover-slipped
with DPX (VWR, Leighton Buzzard, UK).
Investigators blind to the treatment groups performed
the analyses. Counts of TUNEL and Olig2 positive cells
were made in three non-overlapping ﬁelds of view for
each brain region at two levels at 40 magniﬁcation
(0.15 mm2 per ﬁeld). The activation state of Iba-1 positive
cells was assessed by scoring the process number, process
complexity (primary, secondary and tertiary), and relative
intensity of the soma staining from 0 to 4 (score 0, thin
process with tertiary branches and able to visualize the
cresyl violet counterstain through the Iba-1 of the soma;
score 1, tertiary processes but increased staining intensity
of the soma; score 2, reduced numbers of tertiary pro-
cesses and thickening of secondary processes with intense
enlarged soma; score 3, loss of secondary processes and
short thickened primary with intense soma; score 4, no
process and intensely stained soma). Scores were taken of
four cells per FOV at 20 magniﬁcation (at set positions
from the corners of the image) for a total of 24 cells per
region per animal. Two investigators, blinded to treat-
ment group, scored each image independently and their
scores were averaged. The levels of astroglial activation
and endothelial cell nitric oxide synthase expression were
assessed via S100B and eNOS immunoreactivity, respect-
ively. Mean and standard deviation of optical luminosity
values were measured in 3 non-overlapping ﬁelds (20
magniﬁcation) of the diﬀerent brain regions of eNOS
and S100B stained slides using Optimas 6.5 image soft-
ware. Standard deviation was subtracted from the mean
of each ﬁeld and the resulting value was subtracted from
the value obtained from the surround glass.
For each of the outcomes, TUNEL, Iba-1, S100B,
Olig 2 and eNOS separate linear mixed eﬀects models
were ﬁtted (using log transformed data for the S100B
and TUNEL outcomes to satisfy normality assump-
tions) in order to investigate the eﬀect of RIPostC
after HI compared to no treatment. Including a
random subject eﬀect in the model allowed for correl-
ations between observations from the same subject that
arise from repeated measurements, as each outcome is
measured in several ﬁelds in each area of the brain. It is
assumed that the correlation between any two observa-
tions from the same subject is constant, and that obser-
vations from diﬀerent subjects are independent. For
each outcome, estimation of the ﬁxed treatment eﬀect
was carried out using restricted maximum likelihood in
order to obtain unbiased estimates from the small
sample sizes, and was tested using a Wald test. The
Olig2 was analyzed using Poisson mixed eﬀects
models with a random subject eﬀect as above.
Gene expression analysis
RNA extraction. After euthanasia, before perfusion, a
sample of white matter from the opposite hemisphere
to that used for immunohistochemistry was obtained
and placed in RNAlater solution (Qiagen, West
Sussex, UK), frozen in liquid nitrogen and stored at
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80 C until processing. RNA was extracted using the
standard protocol for animal tissues supplied with the
RNAeasy Midi kit (Qiagen, West Sussex, UK). RNA
quality was assessed using a Nanodrop spectrophotom-
eter (NanoDrop, Wilmington, DE, USA) and Agilent
2100 Bioanalyser (Agilent, Santa Clara, CA, USA) and
all samples had a spectral 260/280 ratio of between 2.05
and 2.13, and a RNA Integrity number of 9.9–10.
RNA amplification and microarray hybridization. For each
sample, 200 ng of total RNA was ampliﬁed and labeled
using an Ambion WT expression kit (Invitrogen, Life
Technologies Ltd, Paisley, UK). Brieﬂy, total RNA was
converted to cDNA and then linearly ampliﬁed to
create an antisense cRNA library. This was then con-
verted to single strand sense cDNA, which was frag-
mented and end-labeled before hybridization using a
Gene Chip WT terminal labeling and controls kit
(Aﬀymetrix, California, USA). The ampliﬁed targets
were hybridized to Gene Chip Porcine Genome
Arrays (Aﬀymetrix, California, USA) overnight and
scanned using Gene-Chip Scanner 3000 7 G. Data
ﬁles were extracted from the image ﬁles automatically
by Gene-Chip Command Software (version 2,
Aﬀymetrix, California, USA) and the CEL ﬁle format
was subsequently used for analysis.
Microarray analysis. Analysis was performed using
Genespring GX12 (Agilent, California, USA). Data
from the individual microarray chips was ﬁrst normal-
ized across dataset and summarized using the Robust
Multi-array Analysis (RMA) algorithm. Data were ﬁl-
tered to include only those probe sets falling between
the 20th and 100th percentile after normalization.
Initial analysis with Genespring GX12 probe sets
detected a total of 74 gene transcript sets. We identiﬁed
unknown probe sets using Basic Local Alignment
Search Tool (BLAST) and BLAST-Like Alignment
Tool (BLAT) sequence alignment software against the
pre-labeled mouse genome. Ingenuity Pathway
Analysis software (IPA; Ingenuity Systems,
California, USA) was used to assign the 74 identiﬁed
genes to a range of known biological functions and
metabolic or signaling pathways. Statistical analysis
of microarray data was performed using a one-way
ANOVA followed by a Mann–Whitney unpaired post
hoc test and a Benjamini-Hochberg FDR multiple test-
ing correction. P-values were calculated asymptotically.
Quantitative reverse transcription polymerase chain
reaction. RNA isolated for microarray analysis was
also used for qualitative reverse transcription polymer-
ase reaction (qRT-PCR). Sample preparations, primer
design, and PCR protocol were similar to that previ-
ously described.22 Primers were designed speciﬁcally
using the Sus scrofa Ensembl database and can be
found in Supplementary Table 1. The reference genes
14-3-3 protein zeta/delta (YWAHZ) and ribosomal
protein L4 (Rpl4) were chosen to standardize all quan-
titative experiments. For each duplicate sample, we
averaged the calculated speciﬁc ratio of the gene of
interest/reference gene. Statistical analysis of the qRT-
PCR data was performed by T test or Mann Whitney
depending on whether the data were normally distrib-
uted; p< 0.05 was considered as signiﬁcant.
Results
Physiological data and Insult severity
There were no statistically signiﬁcant intergroup diﬀer-
ences between body weight, postnatal age and baseline
physiological (heart rate and mean arterial blood pres-
sure) measures as shown in Table 1. There was no sig-
niﬁcant diﬀerence in the hypoxic-ischemic insult
severity between the two groups (Table 1). There was
no diﬀerence between groups for volume replacement
and inotrope use following HI (Table 2).
The continuous physiological measurements (blood
oxygen saturation levels, heart rate and mean arterial
blood pressure) during the four RIPostC cycles are
shown in Figure 2. There was no signiﬁcant diﬀerence
between groups in oxygen saturation, HR or MABP
during the cycles. An increase and decrease in MABP
was visible with each RIPostC ischemic and reperfusion
cycle, respectively. There was full recovery of perfusion
to the lower limbs following the four RIPostC cycles
and no leg injuries observed.
MRS analysis showed reduced white matter
injury in the RIPostC group
In one piglet in the RIPostC group, 1H MRS could not
be acquired due to technical problems with the MRI
system. One subject in the HI group had a cardiac
arrest prior to 48 h; this was related to ventilation fail-
ure. 1H MRS was used to measure cerebral Lactate/
Naa and 31P MRS to measure whole brain NTP/epp.
Both these metabolite peak area ratios correlate with
neurodevelopmental outcome in infants with NE.13,16
The diﬀerences between the HI and HIþRIPostC
groups and associated 95% conﬁdence intervals at
each of the three time points (baseline, 24 and 48 h)
are shown in Figure 3(a) and Supplementary Table 2.
White matter Lactate/Naa was signiﬁcantly lower in
the HIþRIPostC group compared to the HI group
at 48 h (p¼ 0.005). NTP/epp was signiﬁcantly higher
at 48 h in the HIþRIPostC group compared to the
HI group (p¼ 0.03). Thalamic 1H MRS showed no dif-
ferences between groups at any time point.
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EEG/aEEG findings
The aEEG background voltage at 6 h after birth is pre-
dictive of neurodevelopmental outcome in NE23 and
the rate of aEEG recovery after HI predicts outcome.24
All piglets had score 3 (normal background voltage) at
baseline. Fitting an ordered logistic regression model to
the data, and allowing for repeated measurements over
time in each pig, there was no evidence of any diﬀerence
in the eﬀect of treatment at diﬀerent time points
(p¼ 0.206).
Histopathology analysis reveals a reduction
in cell death in white matter and higher numbers
of surviving oligodendrocytes with RIPostC
Levels of cell death and changes in glia were measured
using TUNEL staining for fragmented DNA and cell
speciﬁc markers; Iba1 for microglia, S100B for
Table 1. Physiological variables and blood pressure treatment
for piglets in each group.
Parameter
HI
Mean (SD)
HI & RIPostC
Mean (SD) p-value
Post-natal age (h) 35.8 (10.9) 33.0 (10.0) 0.279
Bodyweight (kg) 1.82 (0.22) 1.83 (0.21) 0.645
Duration of HI (min) 20.5 (2.6) 20.6 (1.9) 0.594
Insult severity (102)
measured
from acute energy
depletion (AED)
9.6 (3.3) 9.1 (3.1) 0.194
Rectal temperature (C)
Baseline 38.7 (1.5) 38.5 (0.9) 0.328
Insult nadir 38.5 (0.5) 38.2 (1.0) 0.442
1–24 h post HI 38.5 (0.2) 38.5 (0.2) 0.232
24–48 h post HI 38.5 (0.3) 38.3 (0.2) 0.234
Heart rate (min1)
Baseline 159 (17) 158 (14) 0.189
Insult nadir 178 (17) 159 (21) 0.955
1–24 h post HI 182 (30) 185 (19) 0.482
24–48 h post HI 165 (19) 184 (20) 0.336
MABP (mmHg)
Baseline 54 (6) 47 (10) 0.189
Insult nadir 35 (10) 31 (5) 0.955
1–24 h post HI 51 (3) 49 (4) 0.482
24–48 h post HI 51 (4) 53 (6) 0.336
PaO2 (kPa)
Baseline 12.9 (5.3) 12.2 (4.5) 0.888
Insult nadir 6.1 (1.11) 4.9 (1.0) 0.894
24 h post HI 13.0 (5.45) 18.1 (9.7) 0.161
48 h post HI 26.0 (16.4) 18.6 (4.1) 0.463
PaCO2 (kPa
Baseline 4.5 (1.2) 7.2 (2.2) 0.135
Insult nadir 6.1 (1.8) 7.1 (2.9) 0.805
24 h post HI 5.3 (1.9) 5.2 (1.8) 0.798
48 h post HI 7.4 (4.0) 7.3 (5.3) 0.530
Base excess (mmol/L)
Baseline 7.0 (3.2) 3.5 (4.2) 0.130
Insult nadir 4.7 (3.5) 6.4 (3.3) 0.259
24 h post HI 2.6 (5.2) 0.5 (4.9) 0.574
48 h post HI 4.6 (4.4) 0.0 (3.9) 0.073
Blood lactate (mmol/L)
Baseline 2.8 (0.7) 3.1 (1.0) 0.328
Insult nadir 7.9 (2.7) 9.3 (2.4) 0.152
24 h post HI 3.6 (1.6) 2.6 (1.7) 0.232
48 h post HI 1.1 (0.5) 1.3 (0.9) 0.731
Blood pH
Baseline 7.47 (0.05) 7.43 (0.06) 0.645
(continued)
Table 1. Continued
Parameter
HI
Mean (SD)
HI & RIPostC
Mean (SD) p-value
Insult nadir 7.30 (0.22) 7.23 (0.16) 0.521
24 h post HI 7.45 (0.15) 7.45 (0.08) 0.574
48 h post HI 7.37 (0.20) 7.35 (0.22) 0.699
Haematocrit
Baseline 23.4 (4.9) 20.5 (3.7) 0.279
Insult nadir 23.7 (4.5) 22.0 (5.4) 0.382
24 h post HI 19.9 (4.2) 21.8 (3.0) 0.328
48 h post HI 20.3 (3.2) 21.6 (4.0) 0.537
Note: Time zero was set at the time of reperfusion/resuscitation. Mean
and standard deviation (SD) values are presented for the two groups; (i)
Hypoxia-ischemia (HI) (n¼ 8) and (ii) HI and RIPostC (n¼ 8). Analysis
using Mann Whitney test indicated that there was no evidence of a dif-
ference between the two groups for any of the outcomes at any of the
time-points. Insult severity was estimated by calculating the time integral
of the change in NTP/epp during HI and the first 60 min of resuscitation.
Table 2. Volume and inotrope requirements.
Treatment HI HI & RIPostC
Median (IQR)
Volume replacement (ml/kg/h) 0.8 (0.4–1.1) 0.7 (0.6–0.7)
Dopamine (mcg/kg/min) 7.5 (0.0–15.9) 8.3 (4.0–13.3)
Dobutamine (mcg/kg/min) 0.1 (0.0–4.4) 0.5 (0.0–2.4)
Note: Mean (IQR) values for total volume replacement and dopamine and
dobutamine infusions for the two groups. Analysis using Kruskal–Wallis
equality of populations rank test revealed no evidence of a statistically
significant difference between groups for volume replacement and ino-
trope use.
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astrocytes, and Olig2 for oligodendrocytes. The number
of TUNEL positive cells observed in the HIþRIPostC
versus HI group was signiﬁcantly reduced in all
assessed areas of the white matter: periventricular
white matter, internal capsule, and corpus callosum
(Figure 4 and Supplementary Table 3). RIPostC had
no eﬀect on number of TUNEL positive cell number
in the grey matter regions.
Quantiﬁcation of the numbers of cells expressing
Olig2 showed signiﬁcantly higher number of Olig2 posi-
tive cells in the HIþRIPostC group in the periventricu-
lar white matter and corpus callosum compared to the
HI group (Figure 4). RIPostC increased numbers of
cells expressing Olig2 to similar levels as those seen in
naı¨ve brain in the corpus callosum, but not in the peri-
ventricular white matter (Supplementary Figure 1). We
observed no signiﬁcant diﬀerence in levels of astroglial
activation (S100B) in the HIþRIPostC group versus
HI (Figure 4 and Supplementary Table 3). We observed
a signiﬁcant reduction of microglial activation (Iba1) in
the corpus callosum in the HIþRIPostC group
(p¼ 0.01) in comparison to HI group (Figure 4 and
Supplementary Table 3). There was no signiﬁcant dif-
ference in eNOS expression in the HIþRIPostC group
when compared to HI (Figure 4 and Supplementary
Table 3).
Gene expression analysis
In the microarray analysis, an initial total of 74 genes
were found to be responsive to our RIPostC interven-
tion at the cut oﬀ p< 0.05. Of these 74 genes, 63 were
Figure 2. (a) Oxygen saturation (SpO2), (b) Heart rate (HR) and (c) Mean arterial blood pressure (MABP) during the four RIPostC
limb ischemia/reperfusion cycles. There was no significant difference between groups, although with each RIPostC ischemia/ reper-
fusion cycle there was a corresponding increase/decrease in MABP.
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downregulated and 11 were upregulated. The top 20
identiﬁed gene transcripts with the highest fold-
change in expression are shown in Table 3; all 20
were downregulated. When the Benjamini-Hochberg
FDR multiple testing correction was applied, no candi-
date gene remained signiﬁcant. However, we chose to
use a targeted approach to further investigate a number
of targets with qRT-PCR and these data are shown in
Figure 5. We found that, compared with HI only,
RIPostC cortical tissue had a signiﬁcantly reduced
gene expression for ABCC9 (ATP sensitive potassium
channels ATP-binding cassette, sub-family C member
9), CARPTP (cocaine and amphetamine-regulated
transcript), RGS8 (Regulator of G-protein signaling-
8), and SLC4 (Sodium bicarbonate co-transporter),
and trends for reductions (p< 0.08) were observed in
STRIP2 (striatin Interacting Protein 2) and RGS2.
Discussion
This study in newborn piglets demonstrates selective
protection of cerebral white matter with four 10-
minute cycles of RIPostC (bilateral lower limb ische-
mia/reperfusion) started immediately after a global
cerebral HI insult. Immediate RIPostC improved cere-
bral energy metabolism on localized white matter 1H
MRS (Lactate/Naa) and increased levels of whole brain
cerebral ATP (31P MRS NTP/epp). Correlating with
improved cerebral energy metabolism in the white
matter in the RIPostC group, cell death was reduced
in the periventricular white matter, internal capsule,
and corpus callosum, and there were higher numbers
of oligodendrocytes in the corpus callosum and peri-
ventricular white matter. Microglial activation was
reduced in the corpus callosum. We did not observe
any grey matter protection on IH MRS or immunohis-
tochemistry. We detected changes in expression of a
number of genes following RIPostC treatment in the
periventricular white matter at 48 h after HI, including
the ATP-sensitive potassium channel (KATP) and the
endothelin A receptor.
We monitored brain metabolism using MRS bio-
markers that are known to correlate with injury severity
after HI in the piglet.14,25 and outcome in infants with
NE.26 These biomarkers are currently used as surrogate
outcome measures in clinical neuroprotection studies of
NE (https://www.npeu.ox.ac.uk/toby-xe). High levels
of thalamic Lactate/Naa on MRS in neonates in the
Figure 3. (a–c) Graphs showing metabolite ratios and 95% CIs at baseline, 24 and 48 h from the regression model. (a) WM Lac/Naa,
(b) Thalamic Lac/Naa and (c) NTP/epp. **p¼ 0.005; *p¼ 0.039. epp¼ exchangeable phosphate pool; HI¼ hypoxia–ischemia;
Lac¼ lactate; Naa¼N-acetyl aspartate; Thal¼ thalamic; WM¼white matter.
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Figure 4. RIPostC decreases histological damage in white matter at 48 h after a hypoxic ischemic insult in the neonatal piglet model.
Each column shows representative sections from the same animal in the HI (left column) and HIþRIPostC groups (right column) from
the periventricular white matter (pvWM). The tissue is stained for TUNEL at 20 (a–b) magnification, immunohistochemistry for
microglial IBA1 (d–e), S100 (g–h), Olig 2 (j–k) and eNOS (m–n). Mean cell counts are shown in the right column. Compared to no
treatment after HI, with RIPostC we found significantly reduced TUNEL-positive cells in the internal capsule, periventricular white
matter and corpus callosum (c), reduced IBA-1 scores in the corpus callosum (f) and increased Olig 2 counts in the periventricular
white matter and corpus callosum (l). The arrow in (b) indicates a TUNEL positive cell, seen in the inset at 63 magnification. The
arrow in (d) indicates a highly scored microglial cell with loss of secondary processes and short thickened primary with intense soma
(score 3), seen in the inset at x40 magnification. The arrow in (e) indicates a low scored microglial cell with tertiary processes, but
increased staining intensity of the soma (score 1), seen in the inset at x40 magnification. The arrows in (g) and (h) indicate S100
positive astrocytes. The arrows in (m) and (n) indicate eNOS positive cells. The increase in eNOS in the RIPostC group did not reach
significance (o). HI¼ hypoxia-ischemia; RIPostC¼ remote ischaemic post conditioning; dCTX¼ dorsal parietal cortex,
mCTX¼midtemporal cortex; THAL¼ thalamus; Caudt¼ caudate; PTMN¼ putamen; IC¼ internal capsule; pvWM¼ periventricular
white matter; CC¼ corpus callosum.
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ﬁrst month after birth are predictive of a poor 12–18-
month neurodevelopmental outcome.16,26 In this study,
RIPostC immediately after HI abrogated the white
matter MRS lactate/Naa increases at 48 h and pre-
served whole brain ATP on 31P MRS. Higher ATP
on 31P MRS in infants with NE is associated with
better long-term outcome in clinical studies.13
The protective mechanisms of RIPostC are incom-
pletely understood, but are thought to involve three
closely related pathways (neuronal, humoral and sys-
temic) initiated by the release of endogenous autocoids
(including adenosine, bradykinin and opioids) from the
skeletal muscle.27 The neuronal pathway is triggered via
stimulation of local aﬀerent nerves, leading to remote
protection via eﬀerent nerves including the autonomic
nervous system.28 The humoral pathway involves the
circulation of blood-borne protective factors whose
release is triggered by the limb ischemia and eﬀerent
nerve activation. The systemic pathway describes the
eﬀects on immune function (including reduced neutro-
phil activation) and reduced expression of apoptotic
and inﬂammatory genes. The three pathways converge
on the brain to increase cerebral blood ﬂow, attenuate
inﬂammation, and activate cellular pro-survival
signaling cascades, resulting in mitochondrial protec-
tion, reduced energy demands, increased cell survival,
and activation of repair mechanisms.
Brain injury after perinatal HI is ampliﬁed by
both innate and adaptive immune mechanisms.
Macrophages responsible for innate immunity can be
derived from either residential microglia or monocytes
from peripheral blood. We observed a signiﬁcant reduc-
tion in activated microglia in the corpus callosum with
RIPostC (Figure 4 and Supplementary Table 3). This is
in keeping with other studies, for example in mice,
IPostC blocked inﬁltration of both innate and adaptive
immune cells following focal cerebral ischemia and this
was associated with reduced neurological deﬁcits.29
Our MRS data reﬂect improved mitochondrial
metabolism in the white matter with reduced Lactate/
Naa and overall higher whole brain NTP/epp in the
RIPostC group. Increased cell survival with RIPostC
was seen in the corpus callosum, internal capsule and
periventricular white matter, reﬂected by reduced
TUNEL positive cells. RIPostC also increased oligo-
dendrocyte survival in the periventricular white
matter and corpus callosum, reﬂected by increased
Olig2 staining. The superior cerebral white versus
Table 3. Top 20 identified gene transcripts with the highest fold change in expression by RIPostC.
Gene transcript (Abbreviation) Gene Identification Fold Change P value
Cocaine-and amphetamine-regulated transcript (CARTTP) NM_001099925 3.21 0.012
Mitochondrial specific tRNA for aspartate 2.64 0.021
Protein phosphatase 1 regulatory subunit 1B (PPP1RIB) 2.47 0.012
Regulator of G-protein signalling 2, 24 kDa (RSG2) NM_001044600 2.47 0.009
Matrix Gla protein (GLA) NM_2141167 2.35 0.036
Regulator of G-protein signalling 8-like (RSG8) XM_00357571 2.11 0.006
UPF0672 protein Chromosome X open reading frame 36 homolog (Cxorf36) NC_010461 2.09 0.046
Serglycin (proteoglycan) (Srgn) NC_010461 2.03 0.046
ATP-binding cassette, sub-familyC (CFTR/MRP), member 9 (ABCC9) XM_005655658 2.00 0.021
Long-chain-fatty-acid–CoA ligase ACSBG1-like Acyl-CoA synthetase
bubblegum family member 1 (Acsbg1/ mBG1) (Acsbg1mBG1)
XM_005656246.1 1.96 0.006
Endothelin receptor type A (EDNRA) NM_214229.1 1.96 0.046
Glutamate decarboxylase 2 (pancreatic islets and brain, 65 kDa) (GAD2) NM_213895 1.93 0.046
Probable G-protein coupled receptor 88-like striatal specific
G-protein coupled receptor (Gpr 88STRG)
NC_010454.3 1.92 0.006
Calcium/calmodulin-dependent 30,50-cyclic nucleotide phosphodiesterase1B (PDE1B) NC_010454.3 1.92 0.036
Carboxypeptidase M (CPM) 1.2 0.046
Macrophage scavenger receptor 1 (CD204) XM_005672635 1.86 0.046
Solute carrier family 4, sodium bicarbonate cotransporter, member 4 (SLC4A4) NM_001030533.1 1.85 0.027
Translocation associated membrane protein 1 (TRAM1L1) NC_010444 1.85 0.027
Striatin interacting protein 2 (STRIP2) XM_003134694 1.84 0.027
EGF latrophilin and seven transmembrane domain containing 1 (ELTD1) XM_003127914 1.83 0.046
Note: Genes were thought to be affected by RIPostC if their expression was affected by more than 1.5 fold with p< 0.05.
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grey matter protection seen with RIPostC in our piglet
model is intriguing. A vascular component to white
matter protection from RIPostC has been suggested
in a mouse model of vascular cognitive impairment
where RIPostC selectively protected white matter integ-
rity, improved cognitive function, and inhibited inﬂam-
mation and cell death.30 Watershed predominant injury
results from chronic partial hypoxia or severe global
injury and the areas of most damage are the border
zones between the major cerebral arteries. These
border zones are the areas most susceptible to ischemia
from a fall in perfusion pressure. We observed protec-
tion in periventricular white matter, suggesting that
RIPostC preserved the internal vascular watershed ter-
ritories. We saw no improvement in the EEG with
RIPostC, which supports the absence of cortical pro-
tection on immunohistochemistry. Thus, selective pro-
tection of the white matter by RIPostC may open up
opportunities to combine RIPostC with therapies that
target grey matter to provide optimal global protection.
Alternatively, RIPostC may augment white matter
protection when administered with therapies that bene-
ﬁt white and grey matter such as hypothermia31 and
melatonin.21
RIPostC acts at the cellular level to directly protect
the vascular endothelium via KATP channel-dependent
mechanisms.32 Vascular endothelial dysfunction
triggered by ischemia/reperfusion can promote vaso-
constriction and thrombosis thorough loss of endothe-
lium-derived factors such as nitric oxide (NO);
conditioning has been shown to preserve endothelial
function, increase NO production, and decrease adhe-
sion of neutrophils to endothelial cells.33 In our study,
although the increases in eNOS with RIPostC did
not reach statistical signiﬁcance (Figure 4 and
Supplementary Table 3), it is possible that small
changes in NO through Akt activation was one of the
mechanisms leading to white matter protection.
The protective signals from RIPostC activate intra-
cellular survival signaling pathways in the brain.34 We
observed changes caused by RIPostC in several genes
previously associated with RIPostC neuroprotection.
Figure 5. Real-Time qRT-PCR (Real Time quantitative Reverse Transcription PCR) of periventricular white matter tissue in HI and
HIþRIPostC groups. In the white matter, compared with HI only, RIPostC had a significantly reduced gene expression for ABCC9
(ATP sensitive potassium channels ATP-binding cassette, sub-family C member 9), CART (cocaine and amphetamine-regulated tran-
script), RGS8 (Regulator of G-protein signaling-8) and SLC4 (Sodium bicarbonate co-transporter) and trends for reductions (p< 0.08)
were observed in STRIP2 (striatin Interacting Protein 2) and RGS2.
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The opening of the mitochondrial KATP channels is one
of the endpoints of the postconditioning stimulus. We
observed that a transcript required for both the forma-
tion of ATP-sensitive potassium channels and the
cardioprotective eﬀects of pre- and post-conditioning,
the ATP-binding cassette, sub-family C (CFTR/MRP),
member 9 (ABCC9) was down-regulated (2 fold using
both microarray and qRT-PCR). The endothelin recep-
tor-A, another gene transcript required for pre-condi-
tioning, was down-regulated (1.96 fold microarray,
3.00 fold qRT-PCR) and expression of its putative
receptor ligand CARPTP was also reduced (3.21
fold microarray and 3.00 fold qRT-PCR). RIPostC
also induced a reduction in gene expression for two
genes involved in the negative regulation of G pro-
tein-coupled receptor (GPCR) signal transduction
pathways, RG8 which inhibits M1 muscarinic acetyl
choline GPCR receptor signaling which is required to
induce post-conditioning (2.11 fold microarray, 3
fold qRT-PCR) and RGS2 which is a negative regula-
tor of Angiotensin II GPCR signaling (2.47 fold
microarray, 5 fold qRT-PCR). These data are com-
plex as we are unable to assess changes in expression at
multiple time points; at 48 h, some signaling pathways
involved in RIPostC mediated neuroprotection may be
subjected to negative feedback.
RIPostC was applied to both hind limbs immedi-
ately after the onset of cerebral reperfusion by a remo-
tely controlled external device placed on the inguinal
crease. We chose the RIPostC stimulus with four
cycles of 10-min ischemia/reperfusion in both hind
limbs. Ten minutes ischemia was optimal as longer per-
iods of ischemia up to 15min led to irreversible limb
damage in our pilot studies. Both hind limbs were used
for the stimulus to increase the muscle mass aﬀected
and to optimize the protective response. A recent clin-
ical trial showed better protection with two cycles of leg
ischemia than three cycles in arm,35 suggesting that the
mass of the ischemic muscle is an important factor for
organ protection. We used a custom-made remotely
controlled external device (Patent: SMK/LP6981443)
placed over the inguinal area. There was full recovery
of perfusion to the lower limbs following the four
RIPostC cycles and no leg injuries observed.
Our study has some limitations. We used only female
piglets to minimize the eﬀect of isoﬂurane conditioning
described in male piglets.36 This diﬀers from our previ-
ous studies where male piglets were used.21,31 The more
debilitating eﬀect of hypoxia-ischemia on outcomes in
males versus females is well known, although in a
recent rodent study there was no sex diﬀerence in the
neuropathology scores.37 RIPostC will require assess-
ment in male piglets to ensure beneﬁt is maintained. We
were required to use fentanyl for sedation in both
experimental groups throughout the experiment due
to ethical requirements. A previous RIPostC study in
neonatal rat pups demonstrated protection against neo-
natal hypoxic-ischemic brain injury through activation
of the opioid receptor pathway;11 because of the fen-
tanyl use, we could not assess these pathways in this
study. The gene studies were exploratory; the single
48 h may be subjected to negative feedback and there-
fore mask evolving signaling pathways involved in
RIPostC mediated neuroprotection.
Postconditioning is a potent strategy that can
modify reperfusion-induced adverse eﬀects that include
defense against oxidants, pro-inﬂammatory cytokines,
neutrophils, and pro-apoptotic regulators and so
encompasses a broad therapeutic approach.6 Most clin-
ical applications are in myocardial injury; for example,
postconditioning improves revascularization following
myocardial infarction.6 Huge advances have been made
in the last 10 years regarding our understanding of
mechanisms and potential use in the clinical arena; a
workshop in 2014 outlined the importance of precon-
ditioning in acute renal and liver disease as well as in
stroke and various cardiac interventions.38 In adult
stroke, a recent study of 443 adults who underwent
pre-hospital remote ischemic per-conditioning as an
adjunct to thrombolysis for acute ischemic stroke
found a reduced risk of tissue infarction in the treat-
ment group.39 Remote ischemic conditioning was safe
and well tolerated.
This study shows cerebral white matter protection
with four cycles of limb RIPostC started immediately
after a global cerebral hypoxic ischemic injury in female
newborn piglets. We demonstrate white matter protec-
tion using established brain MRS markers of injury and
immunohistochemistry. RIPostC inﬂuenced the expres-
sion of a number of genes thought to mediate the eﬀects
of pre/post conditioning. It will be important to assess
the therapeutic window of RIPostC and whether
RIPostC augments therapeutic hypothermia in pre-
clinical studies of perinatal hypoxia-ischemia before
studies in babies could be considered. Other challenges
include the determination of the optimal number and
duration of ischemia/reperfusion cycles while avoiding
any detrimental eﬀects and a better understanding of
the precise protective mechanisms.40
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